| http://dbpedia.org/ontology/abstract
|
Intercept Pharmaceuticals, Inc. is an Amer … Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.e intestinal disorder, bile acid diarrhea.
|
| http://dbpedia.org/ontology/foundingYear
|
2002
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/President_%28corporate_title%29 +
, http://dbpedia.org/resource/Chief_Executive_Officer +
|
| http://dbpedia.org/ontology/revenue
|
2.502E8
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/InterceptlogoV2.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.interceptpharma.com/about +
, http://www.interceptpharma.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
42261752
|
| http://dbpedia.org/ontology/wikiPageLength
|
6126
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1114099310
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Obeticholic_acid +
, http://dbpedia.org/resource/Morristown%2C_New_Jersey +
, http://dbpedia.org/resource/Russell_2000_Index +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Non-alcoholic_fatty_liver_disease +
, http://dbpedia.org/resource/Category:Companies_based_in_Morris_County%2C_New_Jersey +
, http://dbpedia.org/resource/Primary_biliary_cirrhosis +
, http://dbpedia.org/resource/Bile_acid_diarrhea +
, http://dbpedia.org/resource/Biomarker +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/TGR5 +
, http://dbpedia.org/resource/Primary_sclerosing_cholangitis +
, http://dbpedia.org/resource/Farnesoid_X_receptor +
, http://dbpedia.org/resource/NASDAQ +
, http://dbpedia.org/resource/Non-alcoholic_steatohepatitis +
, http://dbpedia.org/resource/Cirrhosis +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Portal_hypertension +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/National_Institute_of_Diabetes_and_Digestive_and_Kidney_Diseases +
, http://dbpedia.org/resource/President_%28corporate_title%29 +
, http://dbpedia.org/resource/Alkaline_phosphatase +
|
| http://dbpedia.org/property/foundation
|
2002
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Paolo Fundarò
, Jerome Durso
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Morristown%2C_New_Jersey +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/logo
|
InterceptlogoV2.jpg
|
| http://dbpedia.org/property/logoSize
|
200
|
| http://dbpedia.org/property/name
|
Intercept Pharmaceuticals
|
| http://dbpedia.org/property/revenue
|
2.502E8
|
| http://dbpedia.org/property/tradedAs
|
http://dbpedia.org/resource/Russell_2000_Index +
, NASDAQ:ICPT
|
| http://dbpedia.org/property/type
|
Public company
|
| http://dbpedia.org/property/website
|
http://www.interceptpharma.com +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Template:Coord +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/Category:Companies_based_in_Morris_County%2C_New_Jersey +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
|
| http://www.georss.org/georss/point
|
40.678631 -78.243038
|
| http://www.w3.org/2003/01/geo/wgs84 pos#geometry
|
POINT(-78.243034362793 40.678630828857)
|
| http://www.w3.org/2003/01/geo/wgs84 pos#lat
|
40.678630828857
|
| http://www.w3.org/2003/01/geo/wgs84 pos#long
|
-78.243034362793
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.476455.1 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Intercept_Pharmaceuticals?oldid=1114099310&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/InterceptlogoV2.jpg +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.interceptpharma.com +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Intercept_Pharmaceuticals +
|
| http://xmlns.com/foaf/0.1/name
|
Intercept Pharmaceuticals
|
| owl:sameAs |
http://www.wikidata.org/entity/Q16997126 +
, https://global.dbpedia.org/id/fPiK +
, http://yago-knowledge.org/resource/Intercept_Pharmaceuticals +
, http://dbpedia.org/resource/Intercept_Pharmaceuticals +
, http://rdf.freebase.com/ns/m.04f95dh +
|
| rdf:type |
http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/class/yago/Company108058098 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/ontology/Agent +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnNASDAQ +
, http://www.w3.org/2003/01/geo/wgs84_pos#SpatialThing +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://www.wikidata.org/entity/Q24229398 +
|
| rdfs:comment |
Intercept Pharmaceuticals, Inc. is an Amer … Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.e intestinal disorder, bile acid diarrhea.
|
| rdfs:label |
Intercept Pharmaceuticals
|
